{"title_page": "Obesity paradox", "text_new": "The '''obesity paradox''' is a medical [[hypothesis]] which holds that [[obesity]] (and [[hypercholesterolemia|high cholesterol]], when the more global term \"reverse epidemiology\" is used) may, [[counterintuitive]]ly, be protective and associated with greater survival in certain groups of people, such as very [[Old age|elderly individuals]] or those with certain [[chronic disease]]s.<ref>{{cite journal |last1=Flegal |first1=Katherine |last2=Kit |first2=Brian |last3=Orpana |first3=Heather |title=Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories |journal=Journal of the American Medical Association |date=2 January 2013 |url=https://jamanetwork.com/journals/jama/fullarticle/1555137 |accessdate=26 September 2019}}</ref><ref>{{cite journal |last1=Carnethon |first1=Mercedes |last2=De Chaves |first2=Peter John |last3=Biggs |first3=Mary |title=Association of Weight Status with Mortality in Adults with Incident Diabetes |journal=Journal of the American Medical Association |date=8 August 2012 |url=https://jamanetwork.com/journals/jama/fullarticle/1309174 |accessdate=26 September 2019}}</ref> It further postulates that normal to low [[body mass index]] or normal values of [[cholesterol]] may be detrimental and associated with higher [[Mortality rate|mortality]] in asymptomatic people.\n\n== Description ==\nThe terminology \"reverse epidemiology\" was first proposed by [[Kamyar Kalantar-Zadeh]] in the journal ''[[Kidney International]]'' in 2003<ref>{{cite journal |doi=10.1046/j.1523-1755.2003.00803.x |title=Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients |year=2003 |last1=Kalantar-Zadeh |first1=Kamyar |last2=Block |first2=Gladys |last3=Humphreys |first3=Michael H. |last4=Kopple |first4=Joel D. |journal=Kidney International |volume=63 |issue=3 |pages=793\u2013808 |pmid=12631061}}</ref> and in the ''[[Journal of the American College of Cardiology]]'' in 2004.<ref name=\"[http://fitnesshealthsolutions.com/ Kalantar-Zadeh2\">{{cite journal] |doi=10.1016/j.jacc.2003.11.039 |title=Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure |year=2004 |last1=Kalantar-Zadeh |first1=Kamyar |last2=Block |first2=Gladys |last3=Horwich |first3=Tamara |last4=Fonarow |first4=Gregg C |journal=Journal of the American College of Cardiology |volume=43 |issue=8 |pages=1439\u201344 |pmid=15093881}}</ref> It is a contradiction to prevailing concepts of prevention of [[atherosclerosis]] and [[cardiovascular disease]]; however, active [[prophylaxis|prophylactic treatment]] of heart disease in otherwise healthy, [[asymptomatic]] people is and has been controversial in the medical community for several years.<ref name=\"Naghavi\">{{cite journal |doi=10.1097/01.hpc.0000249784.29151.54 |title=The First SHAPE (Screening for Heart Attack Prevention and Education) Guideline |year=2006 |last1=Naghavi |first1=Morteza |last2=Falk |first2=Erling |last3=Hecht |first3=Harvey S. |last4=Shah |first4=Prediman K. |journal=Critical Pathways in Cardiology |volume=5 |issue=4 |pages=187\u201390 |pmid=18340236 |author5=Shape Task Force}}</ref><ref name=\"Pearson\">{{cite journal |doi=10.1377/hlthaff.26.1.49 |title=The Prevention of Cardiovascular Disease: Have We Really Made Progress? |year=2007 |last1=Pearson |first1=T. A. |journal=Health Affairs |volume=26 |pages=49\u201360 |pmid=17211013 |issue=1}}</ref>\n\nThe mechanism responsible for this reversed association is unknown, but it has been suggested that, in [[chronic kidney disease]] patients, \"The common occurrence of persistent [[inflammation]] and protein energy wasting in advanced CKD [chronic kidney disease] seems to a large extent to account for this paradoxical association between traditional risk factors and CV [cardiovascular] outcomes in this patient population.\"<ref>[http://www.njmonline.nl/article.php?i=122&d=551&a=873 Vascular disease and chronic renal failure: new insights]</ref> Other research has proposed that the paradox may be explained by [[adipose tissue]] storing [[Lipophilicity|lipophilic]] chemicals that would otherwise be toxic to the body.<ref>{{cite journal|last1=Hong|first1=N-S|last2=Kim|first2=K-S|last3=Lee|first3=I-K|last4=Lind|first4=P M|last5=Lind|first5=L|last6=Jacobs|first6=D R|last7=Lee|first7=D-H|title=The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox|journal=International Journal of Obesity|date=27 September 2011|volume=36|issue=9|pages=1170\u20131175|doi=10.1038/ijo.2011.187|pmid=21946706}}</ref>\n\nThe obesity paradox (excluding cholesterol paradox) was first described in 1999 in overweight and obese people undergoing [[hemodialysis]],<ref name=Schmidt2007>{{cite journal |doi=10.1111/j.1525-139X.2007.00349.x |title=CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Obesity-Survival Paradox-Still a Controversy? |year=2007 |last1=Schmidt |first1=Darren S. |last2=Salahudeen |first2=Abdulla K. |journal=Seminars in Dialysis |volume=20 |issue=6 |pages=486\u201392 |pmid=17991192}}</ref> and has subsequently been found in those with [[heart failure]],<ref name=\"Kalantar-Zadeh2\"/><ref>{{cite journal|last1=Sharma|first1=A|last2=Lavie|first2=CJ|last3=Borer|first3=JS|last4=Vallakati|first4=A|last5=Goel|first5=S|last6=Lopez-Jimenez|first6=F|last7=Arbab-Zadeh|first7=A|last8=Mukherjee|first8=D|last9=Lazar|first9=JM|title=Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.|journal=The American Journal of Cardiology|date=15 May 2015|volume=115|issue=10|pages=1428\u201334|doi=10.1016/j.amjcard.2015.02.024|pmid=25772740|url=http://espace.library.uq.edu.au/view/UQ:355802/UQ355802_OA.pdf}}</ref><ref>{{cite journal|last1=Padwal|first1=R|last2=McAlister|first2=F A|last3=McMurray|first3=J J V|last4=Cowie|first4=M R|last5=Rich|first5=M|last6=Pocock|first6=S|last7=Swedberg|first7=K|last8=Maggioni|first8=A|last9=Gamble|first9=G|last10=Ariti|first10=C|last11=Earle|first11=N|last12=Whalley|first12=G|last13=Poppe|first13=K K|last14=Doughty|first14=R N|last15=Bayes-Genis|first15=A|title=The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data|journal=International Journal of Obesity|date=31 October 2013|volume=38|issue=8|pages=1110\u20131114|doi=10.1038/ijo.2013.203|pmid=24173404}}</ref> [[myocardial infarction]],<ref>{{cite journal|last1=Wang|first1=L|last2=Liu|first2=W|last3=He|first3=X|last4=Chen|first4=Y|last5=Lu|first5=J|last6=Liu|first6=K|last7=Cao|first7=K|last8=Yin|first8=P|title=Association of overweight and obesity with patient mortality after acute myocardial infarction: A meta-analysis of prospective studies|journal=International Journal of Obesity|date=4 September 2015|doi=10.1038/ijo.2015.176|pmid=26338077|volume=40|issue=2|pages=220\u20138}}</ref> [[acute coronary syndrome]],<ref>{{cite journal|last1=Niedziela|first1=J|last2=Hudzik|first2=B|last3=Niedziela|first3=N|last4=G\u0105sior|first4=M|last5=Gierlotka|first5=M|last6=Wasilewski|first6=J|last7=Myrda|first7=K|last8=Lekston|first8=A|last9=Polo\u0144ski|first9=L|last10=Rozentryt|first10=P|title=The obesity paradox in acute coronary syndrome: a meta-analysis.|journal=European Journal of Epidemiology|date=November 2014|volume=29|issue=11|pages=801\u201312|doi=10.1007/s10654-014-9961-9|pmid=25354991|pmc=4220102}}</ref> [[chronic obstructive pulmonary disease]] (COPD),<ref>{{cite journal|last1=Cao|first1=Chao|last2=Wang|first2=Ran|last3=Wang|first3=Jianmiao|last4=Bunjhoo|first4=Hansvin|last5=Xu|first5=Yongjian|last6=Xiong|first6=Weining|last7=Simpson|first7=Colin|title=Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis|journal=PLoS ONE|date=24 August 2012|volume=7|issue=8|pages=e43892|doi=10.1371/journal.pone.0043892|pmid=22937118|pmc=3427325}}</ref> and in older [[nursing home]] residents.<ref>{{cite journal|last1=Veronese|first1=N|last2=Cereda|first2=E|last3=Solmi|first3=M|last4=Fowler|first4=SA|last5=Manzato|first5=E|last6=Maggi|first6=S|last7=Manu|first7=P|last8=Abe|first8=E|last9=Hayashi|first9=K|last10=Allard|first10=JP|last11=Arendt|first11=BM|last12=Beck|first12=A|last13=Chan|first13=M|last14=Audrey|first14=YJ|last15=Lin|first15=WY|last16=Hsu|first16=HS|last17=Lin|first17=CC|last18=Diekmann|first18=R|last19=Kimyagarov|first19=S|last20=Miller|first20=M|last21=Cameron|first21=ID|last22=Pitk\u00e4l\u00e4|first22=KH|last23=Lee|first23=J|last24=Woo|first24=J|last25=Nakamura|first25=K|last26=Smiley|first26=D|last27=Umpierrez|first27=G|last28=Rondanelli|first28=M|last29=Sund-Levander|first29=M|last30=Valentini|first30=L|last31=Schindler|first31=K|last32=T\u00f6rm\u00e4|first32=J|last33=Volpato|first33=S|last34=Zuliani|first34=G|last35=Wong|first35=M|last36=Lok|first36=K|last37=Kane|first37=JM|last38=Sergi|first38=G|last39=Correll|first39=CU|title=Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects.|journal=Obesity Reviews|date=November 2015|volume=16|issue=11|pages=1001\u201315|doi=10.1111/obr.12309|pmid=26252230|url=http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-121461}}</ref>\n\nIn people with [[heart failure]], those with a [[body mass index]] between 30.0\u201334.9 had lower mortality than those with what would normally be considered an ideal weight. This has been attributed to the fact that people often lose weight as they become progressively more ill.<ref>{{cite journal |doi=10.1016/j.amjcard.2006.04.039 |title=The Obesity Paradox: Fact or Fiction? |year=2006 |last1=Habbu |first1=Amit |last2=Lakkis |first2=Nasser M. |last3=Dokainish |first3=Hisham |journal=The American Journal of Cardiology |volume=98 |issue=7 |pages=944\u20138 |pmid=16996880}}</ref> Similar findings have been made in other types of heart disease. People with class I obesity and heart disease do not have greater rates of further heart problems than people of normal weight who also have heart disease. In people with greater degrees of obesity, however, risk of further events is increased.<ref>{{cite journal |doi=10.1016/S0140-6736(06)69251-9 |title=Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies |year=2006 |last1=Romero-Corral |first1=Abel |last2=Montori |first2=Victor M |last3=Somers |first3=Virend K |last4=Korinek |first4=Josef |last5=Thomas |first5=Randal J |last6=Allison |first6=Thomas G |last7=Mookadam |first7=Farouk |last8=Lopez-Jimenez |first8=Francisco |journal=The Lancet |volume=368 |issue=9536 |pmid=16920472 |pages=666\u201378}}</ref><ref>{{cite journal |doi=10.1016/j.ahj.2008.02.014 |title=Body mass index and mortality in heart failure: A meta-analysis |year=2008 |last1=Oreopoulos |first1=Antigone |last2=Padwal |first2=Raj |last3=Kalantar-Zadeh |first3=Kamyar |last4=Fonarow |first4=Gregg C. |last5=Norris |first5=Colleen M. |last6=McAlister |first6=Finlay A. |journal=American Heart Journal |volume=156 |pages=13\u201322 |pmid=18585492 |issue=1}}</ref>  Even after [[Coronary artery bypass surgery|cardiac bypass surgery]], no increase in mortality is seen in the overweight and obese.<ref>{{cite journal |doi=10.1038/oby.2007.36 |title=Effect of Obesity on Short- and Long-term Mortality Postcoronary Revascularization: A Meta-analysis |year=2008 |last1=Oreopoulos |first1=Antigone |last2=Padwal |first2=Raj |last3=Norris |first3=Colleen M |last4=Mullen |first4=John C |last5=Pretorius |first5=Victor |last6=Kalantar-Zadeh |first6=Kamyar |journal=Obesity |volume=16 |issue=2 |pages=442\u201350 |pmid=18239657}}</ref><ref>{{cite journal|last1=Mariscalco|first1=G|last2=Wozniak|first2=MJ|last3=Dawson|first3=AG|last4=Serraino|first4=GF|last5=Porter|first5=R|last6=Nath|first6=M|last7=Klersy|first7=C|last8=Kumar|first8=T|last9=Murphy|first9=GJ|title=Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis.|journal=Circulation|date=28 February 2017|volume=135|issue=9|pages=850\u2013863|doi=10.1161/CIRCULATIONAHA.116.022840|pmid=28034901}}</ref> One study found that the improved survival could be explained by the more aggressive treatment obese people receive after a cardiac event.<ref>{{cite journal |doi=10.1016/j.ahj.2005.09.024 |title=The obesity paradox in non\u2013ST-segment elevation acute coronary syndromes: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative |year=2006 |last1=Diercks |first1=Deborah B. |last2=Roe |first2=Matthew T. |last3=Mulgund |first3=Jyotsna |last4=Pollack |first4=Charles V. |last5=Kirk |first5=J. Douglas |last6=Gibler |first6=W. Brian |last7=Ohman |first7=E. Magnus |last8=Smith |first8=Sidney C. |last9=Boden |first9=William E. |last10=Peterson |first10=Eric D. |journal=American Heart Journal |volume=152 |pages=140\u20138 |pmid=16824844 |issue=1|display-authors=8 }}</ref> Another found that if one takes into account COPD in those with [[peripheral artery disease]], the benefit of obesity no longer exists.<ref>[http://www.ima.org.il/FilesUpload/IMAJ/0/40/20270.pdf \"Obesity Paradox\" in Chronic Obstructive Pulmonary Disease]</ref>\n\n== Criticisms ==\n\nThe obesity paradox has been criticized on the grounds of being an [[Artifact (error)|artifact]] arising from [[Sampling bias|biases]] in [[Observational study|observational studies]]. Strong confounding by [[Health effects of tobacco|smoking]] has been noted by several researchers.<ref>{{cite journal |doi=10.1002/oby.21239 |title=Smoking and reverse causation create an obesity paradox in cardiovascular disease. |year=2015 |last1=Stokes |first1=Andrew |journal=Obesity |volume=23 |issue=12 |pages=2485\u201390 |pmid=26421898 |pmc=4701612}}</ref><ref>{{cite journal |doi=10.1097/EDE.0000000000000075 |pmid=24608666 |title=Obesity Paradox: Conditioning on Disease Enhances Biases in Estimating the Mortality Risks of Obesity. |year=2014 |last1=Preston |first1=Samuel |last2=Stokes |first2=Andrew |journal=Epidemiology |volume=25 |issue=3 |pages=454\u2013461|pmc=3984024 }}</ref> Since smokers, who are subject to higher mortality rates, also tend to be leaner, inadequate adjustment for smoking would lead to underestimations of the risk ratios associated with the overweight and obese categories of BMI. In an analysis of 1.46 million individuals, restriction to never-smoking participants greatly reduced the mortality estimates in the underweight group, as well as strengthening the estimates in the overweight and obese groups.<ref name=\"NEJM1\">{{cite journal |authors=Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ |title=Body-mass index and mortality among 1.46 million white adults |journal=The New England Journal of Medicine |volume=363 |issue=23 |pages=2211\u20139 |year=2010 |pmid=21121834 |pmc=3066051 |doi=10.1056/NEJMoa1000367}}</ref> A similar 2016 study found that a low BMI that has been \"induced by healthy lifestyles\" is the best method of reducing the risk of premature death.<ref>Veronese, Nicola; Li, Yanping; Manson, JoAnn E; Willett, Walter C; Fontana, Luigi; Hu, Frank B. (20106) \"Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study\", ''BMJ'', v355. [[Digital object identifier|doi]]: [https://doi.org/10.1136/bmj.i5855 https://doi.org/10.1136/bmj.i5855].</ref>\n\nAnother concern is reverse causation due to illness-induced weight loss. That is, it may not be low BMI that is causing death (and thereby making obesity seem protective) but rather imminent death causing low BMI. Indeed, unintentional weight loss is an extremely significant predictor of mortality.<ref>{{cite journal |doi=10.1017/S0954422409990035 |title=A review and meta-analysis of the effect of weight loss on all-cause mortality risk. |year=2009 |last1=Harrington |first1=Mary |last2=Gibson |first2=Sigrid |last3=Cottrell |first3=Richard |journal=Nutr Res Rev |volume=22 |issue=1 |pages=93\u2013108 |pmid=19555520}}</ref> Terminally ill individuals often undergo weight loss before death, and classifying those individuals as lean greatly inflates the mortality rate in the normal and underweight categories of BMI, while lowering the risk in the higher BMI categories. Studies that employ strategies to reduce reverse causation such as excluding sick individuals at baseline and introducing time lag to exclude deaths at the beginning of follow-up<ref name=\"Lancet1\">{{cite journal |author=Prospective Studies Collaboration |title=Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies |journal=The Lancet |volume=373 |issue=9669 |pages=1083\u20131096 |year=2009 |pmid=19299006 |pmc=2662372 |doi=10.1016/S0140-6736(09)60318-4}}</ref> have yielded estimates of increased risk for body mass indices above 25&nbsp;kg/m<sup>2</sup>. Critics of the \"paradox\" have also argued that studies supporting its existence almost always use BMI as the only measure of obesity. However, because BMI is an imperfect method of measuring obesity, critics argue that studies using other measures of obesity in addition to BMI, such as [[waist circumference]] and [[waist to hip ratio]], render the existence of the \"paradox\" questionable.<ref>{{cite journal|last1=Chrysant|first1=Steven G.|last2=Chrysant|first2=George S.|title=New insights into the true nature of the obesity paradox and the lower cardiovascular risk|journal=Journal of the American Society of Hypertension|date=January 2013|volume=7|issue=1|pages=85\u201394|doi=10.1016/j.jash.2012.11.008|pmid=23321407}}</ref>\n\nOne probable methodological explanation for the obesity paradox is [[Collider (epidemiology)|collider]] [[Stratification (clinical trials)|stratification]] bias, which commonly emerges when one restricts or stratifies on a factor (the \"collider\") that is caused by both the exposure (or its descendants) and the outcome (or its ancestors / risk factors).<ref>{{Cite book|title=Modern epidemiology|last=J.|first=Rothman, Kenneth|others=Greenland, Sander, 1951\u2013, Lash, Timothy L.|isbn=9780781755641|edition=3rd edition, thoroughly revised and updated|location=Philadelphia|oclc=169455558|year = 2008}}</ref><ref name=\":0\">{{Cite journal|last=Banack|first=Hailey R.|last2=Kaufman|first2=Jay S.|date=May 2014|title=The obesity paradox: Understanding the effect of obesity on mortality among individuals with cardiovascular disease|journal=Preventive Medicine|volume=62|pages=96\u2013102|doi=10.1016/j.ypmed.2014.02.003|pmid=24525165|issn=0091-7435}}</ref> \n\n==See also==\n* [[French paradox]]\n* [[Mediterranean diet]]\n* [[Israeli paradox]]\n* [[Diet food]]\n* [[Low birth-weight paradox]] (Low-birth weight babies born to smokers have a lower mortality than low-birth weight babies born to non-smokers, because other causes of low birth-weight are more harmful than smoking.)\n* [[Negative-calorie food]]\n* [[Olestra]]\n* [[Online weight loss plans]]\n\n==References==\n{{reflist}}\n\n==Further reading==\n*{{cite journal |doi=10.1001/jama.2012.9282 |pmid=22871870 |lay-url=http://diabetes.webmd.com/news/20120807/obesity-paradox-thin-not-in-for-type-2-diabetes |laysource=[[WebMD]] |laydate=August 7, 2012 |title=Association of Weight Status With Mortality in Adults With Incident Diabetes |year=2012 |journal=JAMA |volume=000 |issue=8 |pages=9000\u20139001|first1=Mercedes R. |last1=Carnethon |first2=Peter John D. |last2=De Chavez |first3=Mary L. |last3=Biggs |first4=Cora E. |last4=Lewis |first5=James S. |last5=Pankow |first6=Alain G. |last6=Bertoni |first7=Sherita H. |last7=Golden |first8=Kiang |last8=Liu |first9=Kenneth J. |last10=Campbell-Jenkins |first10=Brenda |last11=Dyer |first11=Alan R. |last9=Mukamal|display-authors=8 |pmc=3467944 }}\n*{{cite journal |doi=10.1001/jama.2012.9776 |pmid=22871873 |title=Beyond the Obesity Paradox in Diabetes: Fitness, Fatness, and Mortality |year=2012 |journal=JAMA |volume=308 |issue=6 |pages=619\u2013620|first1=Hermes |last1=Florez |first2=Sumaya |last2=Castillo-Florez}}\n\n[[Category:Epidemiology]]\n[[Category:Hypotheses]]\n[[Category:Obesity]]\n[[Category:Health paradoxes]]\n", "text_old": "The '''obesity paradox''' is a medical [[hypothesis]] which holds that [[obesity]] (and [[hypercholesterolemia|high cholesterol]], when the more global term \"reverse epidemiology\" is used) may, [[counterintuitive]]ly, be protective and associated with greater survival in certain groups of people, such as very [[Old age|elderly individuals]] or those with certain [[chronic disease]]s.<ref>{{cite journal |last1=Flegal |first1=Katherine |last2=Kit |first2=Brian |last3=Orpana |first3=Heather |title=Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories |journal=Journal of the American Medical Association |date=2 January 2013 |url=https://jamanetwork.com/journals/jama/fullarticle/1555137 |accessdate=26 September 2019}}</ref><ref>{{cite journal |last1=Carnethon |first1=Mercedes |last2=De Chaves |first2=Peter John |last3=Biggs |first3=Mary |title=Association of Weight Status with Mortality in Adults with Incident Diabetes |journal=Journal of the American Medical Association |date=8 August 2012 |url=https://jamanetwork.com/journals/jama/fullarticle/1309174 |accessdate=26 September 2019}}</ref> It further postulates that normal to low [[body mass index]] or normal values of [[cholesterol]] may be detrimental and associated with higher [[Mortality rate|mortality]] in asymptomatic people.\n\n== Description ==\nThe terminology \"reverse epidemiology\" was first proposed by [[Kamyar Kalantar-Zadeh]] in the journal ''[[Kidney International]]'' in 2003<ref>{{cite journal |doi=10.1046/j.1523-1755.2003.00803.x |title=Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients |year=2003 |last1=Kalantar-Zadeh |first1=Kamyar |last2=Block |first2=Gladys |last3=Humphreys |first3=Michael H. |last4=Kopple |first4=Joel D. |journal=Kidney International |volume=63 |issue=3 |pages=793\u2013808 |pmid=12631061}}</ref> and in the ''[[Journal of the American College of Cardiology]]'' in 2004.<ref name=\"Kalantar-Zadeh2\">{{cite journal |doi=10.1016/j.jacc.2003.11.039 |title=Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure |year=2004 |last1=Kalantar-Zadeh |first1=Kamyar |last2=Block |first2=Gladys |last3=Horwich |first3=Tamara |last4=Fonarow |first4=Gregg C |journal=Journal of the American College of Cardiology |volume=43 |issue=8 |pages=1439\u201344 |pmid=15093881}}</ref> It is a contradiction to prevailing concepts of prevention of [[atherosclerosis]] and [[cardiovascular disease]]; however, active [[prophylaxis|prophylactic treatment]] of heart disease in otherwise healthy, [[asymptomatic]] people is and has been controversial in the medical community for several years.<ref name=\"Naghavi\">{{cite journal |doi=10.1097/01.hpc.0000249784.29151.54 |title=The First SHAPE (Screening for Heart Attack Prevention and Education) Guideline |year=2006 |last1=Naghavi |first1=Morteza |last2=Falk |first2=Erling |last3=Hecht |first3=Harvey S. |last4=Shah |first4=Prediman K. |journal=Critical Pathways in Cardiology |volume=5 |issue=4 |pages=187\u201390 |pmid=18340236 |author5=Shape Task Force}}</ref><ref name=\"Pearson\">{{cite journal |doi=10.1377/hlthaff.26.1.49 |title=The Prevention of Cardiovascular Disease: Have We Really Made Progress? |year=2007 |last1=Pearson |first1=T. A. |journal=Health Affairs |volume=26 |pages=49\u201360 |pmid=17211013 |issue=1}}</ref>\n\nThe mechanism responsible for this reversed association is unknown, but it has been suggested that, in [[chronic kidney disease]] patients, \"The common occurrence of persistent [[inflammation]] and protein energy wasting in advanced CKD [chronic kidney disease] seems to a large extent to account for this paradoxical association between traditional risk factors and CV [cardiovascular] outcomes in this patient population.\"<ref>[http://www.njmonline.nl/article.php?i=122&d=551&a=873 Vascular disease and chronic renal failure: new insights]</ref> Other research has proposed that the paradox may be explained by [[adipose tissue]] storing [[Lipophilicity|lipophilic]] chemicals that would otherwise be toxic to the body.<ref>{{cite journal|last1=Hong|first1=N-S|last2=Kim|first2=K-S|last3=Lee|first3=I-K|last4=Lind|first4=P M|last5=Lind|first5=L|last6=Jacobs|first6=D R|last7=Lee|first7=D-H|title=The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox|journal=International Journal of Obesity|date=27 September 2011|volume=36|issue=9|pages=1170\u20131175|doi=10.1038/ijo.2011.187|pmid=21946706}}</ref>\n\nThe obesity paradox (excluding cholesterol paradox) was first described in 1999 in overweight and obese people undergoing [[hemodialysis]],<ref name=Schmidt2007>{{cite journal |doi=10.1111/j.1525-139X.2007.00349.x |title=CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Obesity-Survival Paradox-Still a Controversy? |year=2007 |last1=Schmidt |first1=Darren S. |last2=Salahudeen |first2=Abdulla K. |journal=Seminars in Dialysis |volume=20 |issue=6 |pages=486\u201392 |pmid=17991192}}</ref> and has subsequently been found in those with [[heart failure]],<ref name=\"Kalantar-Zadeh2\"/><ref>{{cite journal|last1=Sharma|first1=A|last2=Lavie|first2=CJ|last3=Borer|first3=JS|last4=Vallakati|first4=A|last5=Goel|first5=S|last6=Lopez-Jimenez|first6=F|last7=Arbab-Zadeh|first7=A|last8=Mukherjee|first8=D|last9=Lazar|first9=JM|title=Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.|journal=The American Journal of Cardiology|date=15 May 2015|volume=115|issue=10|pages=1428\u201334|doi=10.1016/j.amjcard.2015.02.024|pmid=25772740|url=http://espace.library.uq.edu.au/view/UQ:355802/UQ355802_OA.pdf}}</ref><ref>{{cite journal|last1=Padwal|first1=R|last2=McAlister|first2=F A|last3=McMurray|first3=J J V|last4=Cowie|first4=M R|last5=Rich|first5=M|last6=Pocock|first6=S|last7=Swedberg|first7=K|last8=Maggioni|first8=A|last9=Gamble|first9=G|last10=Ariti|first10=C|last11=Earle|first11=N|last12=Whalley|first12=G|last13=Poppe|first13=K K|last14=Doughty|first14=R N|last15=Bayes-Genis|first15=A|title=The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data|journal=International Journal of Obesity|date=31 October 2013|volume=38|issue=8|pages=1110\u20131114|doi=10.1038/ijo.2013.203|pmid=24173404}}</ref> [[myocardial infarction]],<ref>{{cite journal|last1=Wang|first1=L|last2=Liu|first2=W|last3=He|first3=X|last4=Chen|first4=Y|last5=Lu|first5=J|last6=Liu|first6=K|last7=Cao|first7=K|last8=Yin|first8=P|title=Association of overweight and obesity with patient mortality after acute myocardial infarction: A meta-analysis of prospective studies|journal=International Journal of Obesity|date=4 September 2015|doi=10.1038/ijo.2015.176|pmid=26338077|volume=40|issue=2|pages=220\u20138}}</ref> [[acute coronary syndrome]],<ref>{{cite journal|last1=Niedziela|first1=J|last2=Hudzik|first2=B|last3=Niedziela|first3=N|last4=G\u0105sior|first4=M|last5=Gierlotka|first5=M|last6=Wasilewski|first6=J|last7=Myrda|first7=K|last8=Lekston|first8=A|last9=Polo\u0144ski|first9=L|last10=Rozentryt|first10=P|title=The obesity paradox in acute coronary syndrome: a meta-analysis.|journal=European Journal of Epidemiology|date=November 2014|volume=29|issue=11|pages=801\u201312|doi=10.1007/s10654-014-9961-9|pmid=25354991|pmc=4220102}}</ref> [[chronic obstructive pulmonary disease]] (COPD),<ref>{{cite journal|last1=Cao|first1=Chao|last2=Wang|first2=Ran|last3=Wang|first3=Jianmiao|last4=Bunjhoo|first4=Hansvin|last5=Xu|first5=Yongjian|last6=Xiong|first6=Weining|last7=Simpson|first7=Colin|title=Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis|journal=PLoS ONE|date=24 August 2012|volume=7|issue=8|pages=e43892|doi=10.1371/journal.pone.0043892|pmid=22937118|pmc=3427325}}</ref> and in older [[nursing home]] residents.<ref>{{cite journal|last1=Veronese|first1=N|last2=Cereda|first2=E|last3=Solmi|first3=M|last4=Fowler|first4=SA|last5=Manzato|first5=E|last6=Maggi|first6=S|last7=Manu|first7=P|last8=Abe|first8=E|last9=Hayashi|first9=K|last10=Allard|first10=JP|last11=Arendt|first11=BM|last12=Beck|first12=A|last13=Chan|first13=M|last14=Audrey|first14=YJ|last15=Lin|first15=WY|last16=Hsu|first16=HS|last17=Lin|first17=CC|last18=Diekmann|first18=R|last19=Kimyagarov|first19=S|last20=Miller|first20=M|last21=Cameron|first21=ID|last22=Pitk\u00e4l\u00e4|first22=KH|last23=Lee|first23=J|last24=Woo|first24=J|last25=Nakamura|first25=K|last26=Smiley|first26=D|last27=Umpierrez|first27=G|last28=Rondanelli|first28=M|last29=Sund-Levander|first29=M|last30=Valentini|first30=L|last31=Schindler|first31=K|last32=T\u00f6rm\u00e4|first32=J|last33=Volpato|first33=S|last34=Zuliani|first34=G|last35=Wong|first35=M|last36=Lok|first36=K|last37=Kane|first37=JM|last38=Sergi|first38=G|last39=Correll|first39=CU|title=Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects.|journal=Obesity Reviews|date=November 2015|volume=16|issue=11|pages=1001\u201315|doi=10.1111/obr.12309|pmid=26252230|url=http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-121461}}</ref>\n\nIn people with [[heart failure]], those with a [[body mass index]] between 30.0\u201334.9 had lower mortality than those with what would normally be considered an ideal weight. This has been attributed to the fact that people often lose weight as they become progressively more ill.<ref>{{cite journal |doi=10.1016/j.amjcard.2006.04.039 |title=The Obesity Paradox: Fact or Fiction? |year=2006 |last1=Habbu |first1=Amit |last2=Lakkis |first2=Nasser M. |last3=Dokainish |first3=Hisham |journal=The American Journal of Cardiology |volume=98 |issue=7 |pages=944\u20138 |pmid=16996880}}</ref> Similar findings have been made in other types of heart disease. People with class I obesity and heart disease do not have greater rates of further heart problems than people of normal weight who also have heart disease. In people with greater degrees of obesity, however, risk of further events is increased.<ref>{{cite journal |doi=10.1016/S0140-6736(06)69251-9 |title=Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies |year=2006 |last1=Romero-Corral |first1=Abel |last2=Montori |first2=Victor M |last3=Somers |first3=Virend K |last4=Korinek |first4=Josef |last5=Thomas |first5=Randal J |last6=Allison |first6=Thomas G |last7=Mookadam |first7=Farouk |last8=Lopez-Jimenez |first8=Francisco |journal=The Lancet |volume=368 |issue=9536 |pmid=16920472 |pages=666\u201378}}</ref><ref>{{cite journal |doi=10.1016/j.ahj.2008.02.014 |title=Body mass index and mortality in heart failure: A meta-analysis |year=2008 |last1=Oreopoulos |first1=Antigone |last2=Padwal |first2=Raj |last3=Kalantar-Zadeh |first3=Kamyar |last4=Fonarow |first4=Gregg C. |last5=Norris |first5=Colleen M. |last6=McAlister |first6=Finlay A. |journal=American Heart Journal |volume=156 |pages=13\u201322 |pmid=18585492 |issue=1}}</ref>  Even after [[Coronary artery bypass surgery|cardiac bypass surgery]], no increase in mortality is seen in the overweight and obese.<ref>{{cite journal |doi=10.1038/oby.2007.36 |title=Effect of Obesity on Short- and Long-term Mortality Postcoronary Revascularization: A Meta-analysis |year=2008 |last1=Oreopoulos |first1=Antigone |last2=Padwal |first2=Raj |last3=Norris |first3=Colleen M |last4=Mullen |first4=John C |last5=Pretorius |first5=Victor |last6=Kalantar-Zadeh |first6=Kamyar |journal=Obesity |volume=16 |issue=2 |pages=442\u201350 |pmid=18239657}}</ref><ref>{{cite journal|last1=Mariscalco|first1=G|last2=Wozniak|first2=MJ|last3=Dawson|first3=AG|last4=Serraino|first4=GF|last5=Porter|first5=R|last6=Nath|first6=M|last7=Klersy|first7=C|last8=Kumar|first8=T|last9=Murphy|first9=GJ|title=Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis.|journal=Circulation|date=28 February 2017|volume=135|issue=9|pages=850\u2013863|doi=10.1161/CIRCULATIONAHA.116.022840|pmid=28034901}}</ref> One study found that the improved survival could be explained by the more aggressive treatment obese people receive after a cardiac event.<ref>{{cite journal |doi=10.1016/j.ahj.2005.09.024 |title=The obesity paradox in non\u2013ST-segment elevation acute coronary syndromes: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative |year=2006 |last1=Diercks |first1=Deborah B. |last2=Roe |first2=Matthew T. |last3=Mulgund |first3=Jyotsna |last4=Pollack |first4=Charles V. |last5=Kirk |first5=J. Douglas |last6=Gibler |first6=W. Brian |last7=Ohman |first7=E. Magnus |last8=Smith |first8=Sidney C. |last9=Boden |first9=William E. |last10=Peterson |first10=Eric D. |journal=American Heart Journal |volume=152 |pages=140\u20138 |pmid=16824844 |issue=1|display-authors=8 }}</ref> Another found that if one takes into account COPD in those with [[peripheral artery disease]], the benefit of obesity no longer exists.<ref>[http://www.ima.org.il/FilesUpload/IMAJ/0/40/20270.pdf \"Obesity Paradox\" in Chronic Obstructive Pulmonary Disease]</ref>\n\n== Criticisms ==\n\nThe obesity paradox has been criticized on the grounds of being an [[Artifact (error)|artifact]] arising from [[Sampling bias|biases]] in [[Observational study|observational studies]]. Strong confounding by [[Health effects of tobacco|smoking]] has been noted by several researchers.<ref>{{cite journal |doi=10.1002/oby.21239 |title=Smoking and reverse causation create an obesity paradox in cardiovascular disease. |year=2015 |last1=Stokes |first1=Andrew |journal=Obesity |volume=23 |issue=12 |pages=2485\u201390 |pmid=26421898 |pmc=4701612}}</ref><ref>{{cite journal |doi=10.1097/EDE.0000000000000075 |pmid=24608666 |title=Obesity Paradox: Conditioning on Disease Enhances Biases in Estimating the Mortality Risks of Obesity. |year=2014 |last1=Preston |first1=Samuel |last2=Stokes |first2=Andrew |journal=Epidemiology |volume=25 |issue=3 |pages=454\u2013461|pmc=3984024 }}</ref> Since smokers, who are subject to higher mortality rates, also tend to be leaner, inadequate adjustment for smoking would lead to underestimations of the risk ratios associated with the overweight and obese categories of BMI. In an analysis of 1.46 million individuals, restriction to never-smoking participants greatly reduced the mortality estimates in the underweight group, as well as strengthening the estimates in the overweight and obese groups.<ref name=\"NEJM1\">{{cite journal |authors=Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ |title=Body-mass index and mortality among 1.46 million white adults |journal=The New England Journal of Medicine |volume=363 |issue=23 |pages=2211\u20139 |year=2010 |pmid=21121834 |pmc=3066051 |doi=10.1056/NEJMoa1000367}}</ref> A similar 2016 study found that a low BMI that has been \"induced by healthy lifestyles\" is the best method of reducing the risk of premature death.<ref>Veronese, Nicola; Li, Yanping; Manson, JoAnn E; Willett, Walter C; Fontana, Luigi; Hu, Frank B. (20106) \"Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study\", ''BMJ'', v355. [[Digital object identifier|doi]]: [https://doi.org/10.1136/bmj.i5855 https://doi.org/10.1136/bmj.i5855].</ref>\n\nAnother concern is reverse causation due to illness-induced weight loss. That is, it may not be low BMI that is causing death (and thereby making obesity seem protective) but rather imminent death causing low BMI. Indeed, unintentional weight loss is an extremely significant predictor of mortality.<ref>{{cite journal |doi=10.1017/S0954422409990035 |title=A review and meta-analysis of the effect of weight loss on all-cause mortality risk. |year=2009 |last1=Harrington |first1=Mary |last2=Gibson |first2=Sigrid |last3=Cottrell |first3=Richard |journal=Nutr Res Rev |volume=22 |issue=1 |pages=93\u2013108 |pmid=19555520}}</ref> Terminally ill individuals often undergo weight loss before death, and classifying those individuals as lean greatly inflates the mortality rate in the normal and underweight categories of BMI, while lowering the risk in the higher BMI categories. Studies that employ strategies to reduce reverse causation such as excluding sick individuals at baseline and introducing time lag to exclude deaths at the beginning of follow-up<ref name=\"Lancet1\">{{cite journal |author=Prospective Studies Collaboration |title=Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies |journal=The Lancet |volume=373 |issue=9669 |pages=1083\u20131096 |year=2009 |pmid=19299006 |pmc=2662372 |doi=10.1016/S0140-6736(09)60318-4}}</ref> have yielded estimates of increased risk for body mass indices above 25&nbsp;kg/m<sup>2</sup>. Critics of the \"paradox\" have also argued that studies supporting its existence almost always use BMI as the only measure of obesity. However, because BMI is an imperfect method of measuring obesity, critics argue that studies using other measures of obesity in addition to BMI, such as [[waist circumference]] and [[waist to hip ratio]], render the existence of the \"paradox\" questionable.<ref>{{cite journal|last1=Chrysant|first1=Steven G.|last2=Chrysant|first2=George S.|title=New insights into the true nature of the obesity paradox and the lower cardiovascular risk|journal=Journal of the American Society of Hypertension|date=January 2013|volume=7|issue=1|pages=85\u201394|doi=10.1016/j.jash.2012.11.008|pmid=23321407}}</ref>\n\nOne probable methodological explanation for the obesity paradox is [[Collider (epidemiology)|collider]] [[Stratification (clinical trials)|stratification]] bias, which commonly emerges when one restricts or stratifies on a factor (the \"collider\") that is caused by both the exposure (or its descendants) and the outcome (or its ancestors / risk factors).<ref>{{Cite book|title=Modern epidemiology|last=J.|first=Rothman, Kenneth|others=Greenland, Sander, 1951\u2013, Lash, Timothy L.|isbn=9780781755641|edition=3rd edition, thoroughly revised and updated|location=Philadelphia|oclc=169455558|year = 2008}}</ref><ref name=\":0\">{{Cite journal|last=Banack|first=Hailey R.|last2=Kaufman|first2=Jay S.|date=May 2014|title=The obesity paradox: Understanding the effect of obesity on mortality among individuals with cardiovascular disease|journal=Preventive Medicine|volume=62|pages=96\u2013102|doi=10.1016/j.ypmed.2014.02.003|pmid=24525165|issn=0091-7435}}</ref> \n\n==See also==\n* [[French paradox]]\n* [[Mediterranean diet]]\n* [[Israeli paradox]]\n* [[Diet food]]\n* [[Low birth-weight paradox]] (Low-birth weight babies born to smokers have a lower mortality than low-birth weight babies born to non-smokers, because other causes of low birth-weight are more harmful than smoking.)\n* [[Negative-calorie food]]\n* [[Olestra]]\n* [[Online weight loss plans]]\n\n==References==\n{{reflist}}\n\n==Further reading==\n*{{cite journal |doi=10.1001/jama.2012.9282 |pmid=22871870 |lay-url=http://diabetes.webmd.com/news/20120807/obesity-paradox-thin-not-in-for-type-2-diabetes |laysource=[[WebMD]] |laydate=August 7, 2012 |title=Association of Weight Status With Mortality in Adults With Incident Diabetes |year=2012 |journal=JAMA |volume=000 |issue=8 |pages=9000\u20139001|first1=Mercedes R. |last1=Carnethon |first2=Peter John D. |last2=De Chavez |first3=Mary L. |last3=Biggs |first4=Cora E. |last4=Lewis |first5=James S. |last5=Pankow |first6=Alain G. |last6=Bertoni |first7=Sherita H. |last7=Golden |first8=Kiang |last8=Liu |first9=Kenneth J. |last10=Campbell-Jenkins |first10=Brenda |last11=Dyer |first11=Alan R. |last9=Mukamal|display-authors=8 |pmc=3467944 }}\n*{{cite journal |doi=10.1001/jama.2012.9776 |pmid=22871873 |title=Beyond the Obesity Paradox in Diabetes: Fitness, Fatness, and Mortality |year=2012 |journal=JAMA |volume=308 |issue=6 |pages=619\u2013620|first1=Hermes |last1=Florez |first2=Sumaya |last2=Castillo-Florez}}\n\n[[Category:Epidemiology]]\n[[Category:Hypotheses]]\n[[Category:Obesity]]\n[[Category:Health paradoxes]]\n", "name_user": "Zeeshan Ali 880", "label": "safe", "comment": "\u2192\u200eDescription", "url_page": "//en.wikipedia.org/wiki/Obesity_paradox"}
